Mercaptopurine

Overview

Medicine Type :
Allopathy

Prescription Type:
Prescription Required

Approval :
DCGI (Drugs Controller General of India)

Schedule
Schedule H

Pharmacological Class:

Antimetabolites, Immunomodulatory agents,

Therapy Class:

Antineoplastic agent,

Approved Countries

India, the United States, Canada, the United Kingdom, Germany, Australia, Japan, France, Italy, and Spain

References

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Purixan (mercaptopurine)
https://www.ncbi.nlm.nih.gov/books/NBK557620/
KD Tripathi. Essentials of Medical Pharmacology. Eighth Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2019
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009053s040lbl.pdf

Authored by

Chumbeni

Dr. Chumbeni E Lotha has completed her Bachelor of Pharmacy from RIPANS, Mizoram and Doctor of Pharmacy from SGRRU,Dehradun. She can be reached at editorial@medicaldialogues.in

Reviewed by

Dr JUHI SINGLA

Dr JUHI SINGLA has completed her MBBS from Era’s Lucknow Medical college and done MD pharmacology from SGT UNIVERSITY Gurgaon. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751